PTEN and TP53 co-deletions/mutations are associated with high levels of the glycolytic enzyme hexokinase 2 in PCa cell lines, xenografts, genetically engineered mouse models (GEMMs), and clinical samples. Here, PTEN is linked to posterior cortical atrophy.